NOVELION THERAPEUTICS INC - COM NEW (NVLNF)

CUSIP: 67001K202

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NEW
Total 13F shares
12,994,304
Share change
+12,982,308
Total reported value
$109,401,000
Put/Call ratio
13%
Price per share
$8.42
Number of holders
59
Value change
+$109,300,003
Number of buys
58

Quarterly Holders Quick Answers

What is CUSIP 67001K202?
CUSIP 67001K202 identifies NVLNF - NOVELION THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVELION THERAPEUTICS INC - COM NEW (NVLNF) as of Q4 2016

As of 31 Dec 2016, NOVELION THERAPEUTICS INC - COM NEW (NVLNF) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,994,304 shares. The largest 10 holders included Broadfin Capital, LLC, Stonepine Capital Management, LLC, ARMISTICE CAPITAL, LLC, SCOPIA CAPITAL MANAGEMENT LP, Sarissa Capital Management LP, Healthcare Value Capital, LLC, FMR LLC, KINGSTOWN CAPITAL MANAGEMENT L.P., Ancora Advisors, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 59 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.